Published in Basic Res Cardiol on October 17, 1979
Effect of surface active agents on the latent ATPase of mitochondria. Biochim Biophys Acta (1956) 2.20
Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation (1972) 2.10
Uncoupling activity of long-chain fatty acids. Biochim Biophys Acta (1962) 1.94
The nature and mechanism of action of uncoupling agents present in mitochrome preparations. Biochim Biophys Acta (1960) 1.75
Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs. Circ Res (1973) 1.65
Effects of glucose, insulin and potassium infusion on tissue metabolic changes within first hour of myocardial infarction in the baboon. Circulation (1975) 1.39
Effect of ethanol on metabolism and function of perfused rat heart. Am Heart J (1969) 1.11
Pharmacological protection of mitochondrial function in hypoxic heart muscle: Effect of verapamil, propranolol, and methylprednisolone. Cardiovasc Res (1978) 1.03
Mitochondrial oxidative phosphorylation in low-flow hypoxia: role of free fatty acids. J Mol Cell Cardiol (1978) 0.92
OXIDATIVE PHOSPHORYLATION IN CARDIAC INFARCT. EFFECT OF GLUCOSE-KCL-INSULIN SOLUTION. Am J Physiol (1965) 0.89
Propranolol and experimental myocardial infarction: substrate effects. Postgrad Med J (1976) 0.89
Exogenous substrate effects on endogenous lipid metabolism in the working rat heart. Biochim Biophys Acta (1972) 0.88
Mitochondrial biochemical changes and glucose-KCl-insulin solution in cardiac infarct. Am J Physiol (1966) 0.87
Oxidative phosphorylation in infarcting baboon and dog myocardium: effects of mitochondrial isolation and incubation media. J Mol Cell Cardiol (1975) 0.84
Effect of propranolol on catecholamine content of injured cardiac tissue. J Mol Cell Cardiol (1971) 0.82
Mitochondrial oxidative phosphorylation in myocardial ischaemia: effects of glycerol, glucose and insulin on anoxic hearts perfused at low pressure. J Mol Cell Cardiol (1976) 0.81
The hypoxic, low-flow perfused rat heart: characterization as a model of global ischaemia. Basic Res Cardiol (1979) 0.79
The effects of adenine nucleotides on carbohydrate metabolism in pigeon-liver homogenates. Biochem J (1966) 3.20
The maximum oxygen intake. An international reference standard of cardiorespiratory fitness. Bull World Health Organ (1968) 2.87
Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment. Nature (1977) 2.44
Preservation of myocardial function and biochemistry after blood and oxygenated crystalloid cardioplegia during cardiac arrest. Ann Thorac Surg (1990) 2.19
Control of glycolysis and gluconeogenesis in liver and kidney cortex. Vitam Horm (1967) 1.84
Glycoprotein, elastin, and collagen secretion by rat smooth muscle cells. Proc Natl Acad Sci U S A (1979) 1.71
Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects. J Clin Invest (1990) 1.58
The activation of amino acids for biosynthesis of gramicidin S. Proc Natl Acad Sci U S A (1968) 1.52
Action limits for serum total cholesterol. A statement for the medical profession by an ad hoc committee of the Heart Foundation of Southern Africa. S Afr Med J (1988) 1.48
Peptidyl transfers in gramicidin S bisoynthesis from enzyme-bound thioester intermediates. Proc Natl Acad Sci U S A (1969) 1.47
Tyrocidine biosynthesis by three complementary fractions from Bacillus brevis (ATCC 8185). Biochemistry (1970) 1.42
Opioid receptor stimulation acts as mediator of protection in ischaemic preconditioning. Cardiovasc J S Afr (2001) 1.41
Protons in ischemia: where do they come from; where do they go to? J Mol Cell Cardiol (1991) 1.39
Acclimatization to humid heat and the role of physical conditioning. J Appl Physiol (1966) 1.39
Oxygen requirements of the isolated rat heart during hypothermic cardioplegia. Effect of oxygenation on metabolic and functional recovery after five hours of arrest. J Thorac Cardiovasc Surg (1988) 1.37
Generation of protons by metabolic processes in heart cells. J Mol Cell Cardiol (1977) 1.29
Polypeptide synthesis on protein templates: the enzymatic synthesis of gramicidin S and tyrocidine. Adv Enzymol Relat Areas Mol Biol (1971) 1.27
Standardization of submaximal exercise tests. Bull World Health Organ (1968) 1.23
Isolation of enzyme-bound peptide intermediates in tyrocidine biosynthesis. Biochemistry (1970) 1.19
The regulation of phosphoenolpyruvate synthesis in pigeon liver. Biochem J (1967) 1.16
Imbalance of T cell subpopulations in patients with chronic lymphocytic leukaemia of the B cell type. Clin Exp Immunol (1982) 1.14
Interrelation between activation and polymerization in gramicidin S biosynthesis. Proc Natl Acad Sci U S A (1969) 1.12
Effect of ethanol on metabolism and function of perfused rat heart. Am Heart J (1969) 1.11
Changes in central circulation and body fluid spaces during acclimatization to heat. J Appl Physiol (1968) 1.10
Effects of sodium butyrate on the synthesis and methylation of DNA in normal cells and their transformed counterparts. Cancer Res (1986) 1.04
Low density lipoprotein receptor mutations in South African homozygous familial hypercholesterolemic patients. Arteriosclerosis (1984) 1.03
At the core of survival: autophagy delays the onset of both apoptotic and necrotic cell death in a model of ischemic cell injury. Exp Cell Res (2011) 1.03
Mitochondrial oxidative phosphorylation in myocardial anoxia: effects of albumin. J Mol Cell Cardiol (1976) 0.99
Ammonium chloride causes reversible inhibition of low density lipoprotein receptor recycling and accelerates receptor degradation. J Biol Chem (1990) 0.99
Enzyme-bound phosphopantetheine in tyrocidine biosynthesis. Biochem Biophys Res Commun (1970) 0.98
A role for the RISK pathway and K(ATP) channels in pre- and post-conditioning induced by levosimendan in the isolated guinea pig heart. Br J Pharmacol (2008) 0.98
Thiamine deficiency and beriberi heart disease. S Afr Med J (1966) 0.98
Physiological requirements for world-class performances in endurance running. S Afr Med J (1969) 0.97
Auto-ubiquitination of ubiquitin-activating enzymes from chicken breast muscle. Biochem J (1990) 0.97
Evidence that recycling of low density lipoprotein receptors does not depend on delivery of receptors to lysosomes. Biochem Biophys Res Commun (1982) 0.96
DNA hypermethylation in sodium butyrate-treated WI-38 fibroblasts. J Biol Chem (1986) 0.96
Ethanol-induced hypoglycemia. I. The acute effects of glucose output and peripheral glucose utilization in fasted dogs. Metabolism (1967) 0.96
Retro-endocytosis of low density lipoprotein by cultured bovine aortic smooth muscle cells. Biochim Biophys Acta (1981) 0.95
Low density lipoprotein receptor degradation is influenced by a mediator protein(s) with a rapid turnover rate, but is unaffected by receptor up- or down-regulation. J Lipid Res (1988) 0.94
Signalling pathways activated by glucagon-like peptide-1 (7-36) amide in the rat heart and their role in protection against ischaemia. Cardiovasc J Afr (2008) 0.93
A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury. Basic Res Cardiol (2005) 0.93
A high-molecular-weight cysteine endopeptidase from rat skeletal muscle. Biochim Biophys Acta (1983) 0.92
Two mutant low-density-lipoprotein receptors in Afrikaners slowly processed to surface forms exhibiting rapid degradation or functional heterogeneity. Biochem J (1988) 0.92
Melatonin and the metabolic syndrome: a tool for effective therapy in obesity-associated abnormalities? Acta Physiol (Oxf) (2012) 0.92
Mitochondrial oxidative phosphorylation in low-flow hypoxia: role of free fatty acids. J Mol Cell Cardiol (1978) 0.92
p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes. Basic Res Cardiol (2004) 0.92
Nonribosomal polypeptide synthesis: the biosynthesis of a cyclic peptide antibiotic, gramicidin S. Cold Spring Harb Symp Quant Biol (1969) 0.90
Radiation-induced changes in the ultrastructure and mechanical function of the rat heart. Radiother Oncol (1989) 0.90
Low-density-lipoprotein receptors in human fibroblasts are not degraded in lysosomes. Biochem J (1989) 0.89
Work performance of the isolated perfused beating heart in the hereditary myocardiopathy of the Syrian hamster. Circ Res (1967) 0.89
Serum triglyceride responses to fatty meals: effects of meal fat content. Am J Clin Nutr (1988) 0.88
Defective oxidative phosphorylation in hereditary myocardiopathy in the Syrian hamster. Cardiovasc Res (1968) 0.87
CREB activation and ischaemic preconditioning. Cardiovasc Drugs Ther (2008) 0.87
Polypeptide biosynthesis form thioesters of amino acids. Arch Biochem Biophys (1971) 0.87
Absence of alpha 2(1) procollagen synthesis in a clone of SV40-transformed WI-38 human fibroblasts. J Biol Chem (1989) 0.87
Dexamethasone-induced cardioprotection: a role for the phosphatase MKP-1? Life Sci (2009) 0.86
ANG II type I receptor antagonism improved nitric oxide production and enhanced eNOS and PKB/Akt expression in hearts from a rat model of insulin resistance. Mol Cell Biochem (2010) 0.86
The significance of biochemical and structural changes in the development of the myocardiopathy of the Syrian hamster. J Mol Cell Cardiol (1970) 0.86
The effects of insulin and beta-adrenergic stimulation on glucose transport, glut 4 and PKB activation in the myocardium of lean and obese non-insulin dependent diabetes mellitus rats. Mol Cell Biochem (2001) 0.86
Ethanol-induced hypoglycemia. II. Mechanism of suppression of hepatic gluconeogenesis. Diabetes (1967) 0.85
Loss of type I procollagen gene expression in SV40-transformed human fibroblasts is accompanied by hypermethylation of these genes. Nucleic Acids Res (1982) 0.85
Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion. J Mol Cell Cardiol (2001) 0.85
Carbohydrate ingestion and muscle glycogen depletion during marathon and ultramarathon racing. Eur J Appl Physiol Occup Physiol (1988) 0.85
The effect of emetine on metabolism and contractility of the isolated rat heart. J Pharmacol Exp Ther (1969) 0.85
Effect of ischaemia and infarction on the metabolism and function of the isolated, perfused rat heart. Cardiovasc Res (1972) 0.84
Serum amino acids in weight-losing patients with cancer and tuberculosis. Eur J Cancer Clin Oncol (1983) 0.84
Increased cardiac myosin ATPase activity as a biochemical adaptation to running training: enhanced response to catecholamines and a role for myosin phosphorylation. J Mol Cell Cardiol (1981) 0.84
The effects of gender and obesity on myocardial tolerance to ischemia. Physiol Res (2010) 0.84
Protein synthesis in the myocardiopathy and muscular dystrophy of the Syrian hamster. Clin Sci (1971) 0.84
Oxidative phosphorylation in infarcting baboon and dog myocardium: effects of mitochondrial isolation and incubation media. J Mol Cell Cardiol (1975) 0.84
Long-chain polyunsaturated fatty acids protect the heart against ischemia/reperfusion-induced injury via a MAPK dependent pathway. J Mol Cell Cardiol (2005) 0.84
Oxidative phosphorylation and glycolysis in the hereditary muscular dystrophy of the Syrian hamster. Clin Sci (1967) 0.84
Myocardial membrane cholesterol: effects of ischaemia. J Mol Cell Cardiol (1991) 0.84
Retro-endocytosis of low density lipoprotein by cultured human skin fibroblasts. Arteriosclerosis (1985) 0.84
Effect of captopril on changes in rats' hearts induced by long-term irradiation. Radiat Res (1993) 0.84
Autophagy in heart disease: a strong hypothesis for an untouched metabolic reserve. Med Hypotheses (2011) 0.83
Low density lipoprotein receptor founder mutations in Afrikaner familial hypercholesterolaemic patients: a comparison of two geographical areas. Hum Genet (1991) 0.83
Dephosphorylation of myofibrillar proteins in actomyosin preparations and in isolated perfused rat hearts after beta-agonist withdrawal. J Mol Cell Cardiol (1982) 0.83
Physiological effects of the amphetamines during exercise. S Afr Med J (1971) 0.83
Sarcolemmal integrity during ischaemia and reperfusion of the isolated rat heart. Basic Res Cardiol (1989) 0.83
Postprandial lipemia and chylomicron clearance in athletes and in sedentary men. Am J Clin Nutr (1989) 0.83
Proposed mechanisms for the anabolic steroid-induced increase in myocardial susceptibility to ischaemia/reperfusion injury. Cardiovasc J S Afr (2005) 0.82
Melatonin protects against ischaemic-reperfusion myocardial damage. J Mol Cell Cardiol (2001) 0.82
A comparison of stimulation frequency and electro-augmentation on myocardial function, extensibility, coronary flow rate, oxygen consumption and glucose metabolism. Eur J Clin Invest (1972) 0.82
Low density lipoprotein metabolism in cultured fibroblasts from a new group of patients presenting clinically with homozygous familial hypercholesterolemia. Arteriosclerosis (1982) 0.82
Ischaemic preconditioning does not protect hypertrophied myocardium against ischaemia. S Afr Med J (1997) 0.82
The effect of ischaemia and reperfusion on sarcolemmal inositol phospholipid and cytosolic inositol phosphate metabolism in the isolated perfused rat heart. Mol Cell Biochem (1991) 0.81
AMP kinase activation and glut4 translocation in isolated cardiomyocytes. Cardiovasc J Afr (2010) 0.81
Oxidative phosphorylation rate: an index for evaluation of mitochondrial function in myocardial ischaemia. J Mol Cell Cardiol (1979) 0.81